| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Aggrenox (Dipyridamole and Aspirin)| 1 | 1999 | Dipyridamole plus aspirin in cerebrovascular disease. | 
| + | - | nl | Arch Neurol 56(9):1087-92 (1999) |
| 2 | 2008 | Aspirin plus dipyridamole versus aspirin for prevention of vascular events after stroke or TIA: a meta-analysis. | 
| + | - | nl | Stroke 39(4):1358-63 (2008) Verro P |
| 3 | 2005 | Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials. | 
| + | - | nl | Stroke 36(1):162-8 (2005) Leonardi-Bee J |
| 4 | 2003 | Cochrane review: dipyridamole for preventing major vascular events in patients with vascular disease. | 
| + | - | nl | Stroke 34(8):2072-80 (2003) De Schryver EL |
| 5 | 2000 | Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. | 
| + | - | nl | Stroke 31(7):1779-84 (2000) |